Sign in

ALCYF on OTC

Alchemy Investments Acquisition Corp 1

Alchemy Investments Acquisition Corp 1 is a blank check company in the Cayman Islands.1 It is headquartered in Newark, Delaware.1 Its shares trade on OTC under the symbol ALCYF.1

Price unavailable

Last updated Oct 21, 2026.

Overview

-$1.1MNet income, fiscal 20252

Compare with another stock.

  • TickerALCYF on OTC1
  • IndustryBlank Checks1
  • HeadquartersNewark, Delaware1
  • Incorporated inCayman Islands3
  • Business address850 Library Avenue, Suite 204-F, Newark, De 197113
  • Filer category, Emerging growth company3

See how the biggest companies compare on our leaderboards

We are a blank check company incorporated on October 27, 2021, as a Cayman Islands exempted company for the purpose of completing a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, which we refer to as our initial business combination. We have neither engaged in any operations nor generated any revenue to date. We have reviewed a number of opportunities to enter into an initial business combination.4 From its latest annual report

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Financial statements

Operating income562-$1.4M in 2025
-$1.5M-$1.0M-$500.0K02022: $0$020222023: -$660.0K-$660.0K20232024: -$1.2M-$1.2M2024+81%2025: -$1.4M-$1.4M2025+20%
Net income562-$1.1M in 2025
-$2.0M0$2.0M$4.0M$6.0M2022: $0$020222023: $3.3M$3.3M20232024: $4.2M$4.2M2024+29%2025: -$1.1M-$1.1M2025

Every line of the income statement as filed: the last 2 fiscal years, latest first.2

Period ending2025-12-312024-12-31
Operating and formation costs$1.4M$1.2M
Loss from operations-$1.4M-$1.2M
Gain on investments held in Trust Account$454.1K$5.5M
Dividend income$11.2K$13.0K
Interest expense - related party-$134.3K-$28.0K
Total other income (expense)$331.0K$5.4M
Net (loss) income-$1.1M$4.2M

Compare Alchemy Investments Acquisition Corp 1 with another company

Corporate structure

Alchemy Investments Acquisition Corp 1 sits at the top of its group. 1 entity, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of Alchemy Investments Acquisition Corp 1

  • AQR CAPITAL MANAGEMENT LLC Filed SCHEDULE 13G/A on Alchemy Investments Acquisition Corp 1, latest Feb 14, 2025 (2 filings since Nov 14, 2024)
  • First Trust Capital Management L.P. Filed SCHEDULE 13G/A on Alchemy Investments Acquisition Corp 1, latest Feb 14, 2025 (2 filings since Nov 15, 2024)
  • COWEN AND COMPANY, LLC Filed SCHEDULE 13G/A on Alchemy Investments Acquisition Corp 1, latest Feb 13, 2025 (2 filings since Nov 13, 2024)
  • Wealthspring Capital LLC Filed SCHEDULE 13G/A on Alchemy Investments Acquisition Corp 1, latest Feb 13, 2025 (2 filings since Jan 10, 2024)
  • WOLVERINE ASSET MANAGEMENT LLC Filed SCHEDULE 13G/A on Alchemy Investments Acquisition Corp 1, latest Jan 31, 2025 (2 filings since Oct 16, 2024)
  • Alchemy DeepTech Capital LLC Filed SC 13G/A on Alchemy Investments Acquisition Corp 1, latest Nov 21, 2024 (2 filings since Feb 9, 2024)
  • Mizuho Financial Group Filed SC 13G on Alchemy Investments Acquisition Corp 1, latest Nov 14, 2024
  • SPRING CREEK CAPITAL LLC Filed SC 13G/A on Alchemy Investments Acquisition Corp 1, latest Aug 9, 2024 (2 filings since Feb 14, 2024)
  • CITADEL ADVISORS LLC Filed SC 13G/A on Alchemy Investments Acquisition Corp 1, latest Feb 14, 2024 (2 filings since May 19, 2023)
  • Alchemy Investments Acquisition Corp 1 Newark, Delaware

Built from major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What Alchemy Investments Acquisition Corp 1 reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$55.0K2 Dec 31, 2025$181.2K2 Dec 31, 2024−69.6%

Properties, in its own words

We maintain our principal executive office at 850 Library Avenue, Suite 204-F, Newark, DE 19711. We consider our current office space adequate for our current operations.

As of the date of this Report, to the knowledge of management, there is no material litigation, arbitration or governmental proceeding currently pending against us, any of our officers or directors in their capacity as such, or against any of our property.

Item 2 of the 10-K filed Apr 9, 2026.4

Leadership

Who has led Alchemy Investments Acquisition Corp 1, and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. Mattia Tomba2023
  2. Vittorio Savoia2023

Chief financial officer

  1. Harshana Sidath Jayaweera2023
2025
Board members and other officers (6)

Former names

  • VAM Acquisition Corp.Dec 29, 2021 to Dec 29, 20213

Timeline

  1. Sep 9, 20268-K Bylaws or fiscal year changed; Shareholder vote18
  2. Sep 4, 20268-K Shareholder vote19
  3. Sep 3, 20268-K Shareholder vote20
  4. May 8, 20268-K Listing notice or transfer21
  5. Apr 7, 20268-K Regulation FD disclosure22
  6. Mar 24, 20268-K Regulation FD disclosure23
  7. Oct 30, 20258-K Regulation FD disclosure24
  8. Sep 10, 20258-K Bylaws or fiscal year changed; Shareholder vote; Other events25
  9. Aug 25, 20258-K Entered a material agreement; Regulation FD disclosure26
  10. May 12, 20258-K Regulation FD disclosure27
  11. Apr 30, 20258-K Change of auditor28
  12. Nov 5, 20248-K Bylaws or fiscal year changed; Shareholder vote; Other events29
  13. May 4, 2023New chief executive Vittorio Savoia becomes CEO12
  14. May 4, 2023New chief executive Mattia Tomba becomes CEO11

Filings

106 filings to the SEC since October 2021: 4 annual reports, 11 quarterly reports, 17 major events, 10 insider forms, 17 large holders, 47 other. The latest 20:

  1. Sep 9, 20268-K EDGAR
  2. Sep 4, 2026DEFA14A EDGAR
  3. Sep 4, 20268-K EDGAR
  4. Sep 3, 20268-K EDGAR
  5. Aug 27, 202610-Q EDGAR
  6. Aug 17, 2026NT 10-Q EDGAR
  7. Jul 29, 2026DEF 14A EDGAR
  8. Jul 16, 2026PRE 14A EDGAR
  9. Jul 10, 202625-NSE EDGAR
  10. May 21, 202610-Q EDGAR
  11. May 18, 2026NT 10-Q EDGAR
  12. May 8, 2026425 EDGAR
  13. May 8, 20268-K EDGAR
  14. Apr 30, 202610-K/A EDGAR
  15. Apr 9, 202610-K EDGAR
  16. Apr 7, 2026425 EDGAR
  17. Apr 7, 20268-K EDGAR
  18. Apr 1, 2026NT 10-K EDGAR
  19. Mar 24, 2026425 EDGAR
  20. Mar 24, 20268-K EDGAR

The 106 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

SEC filer profile

How Alchemy Investments Acquisition Corp 1 is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARAlchemy Investments Acquisition Corp 11
  • CIK0001901336
  • Employer ID (EIN)00-00000004
  • Filer statusNon-accelerated filer an emerging growth company; a smaller reporting company; a shell company4
  • Incorporated inCayman Islands4
  • Fiscal year endsDecember 311
  • Industry code (SIC)6770 Blank Checks1
  • SEC reviewing officeOffice of Real Estate & Construction, Division of Corporation Finance1
  • Business address850 Library Avenue, Suite 204-F, Newark, DE 197111
  • Phone(212) 877-15881
  • Shares outstanding4,208,042 Common Class A shares; 1 Common Class B shares as of Apr 8, 20264
  • Public float$12.4M as of Jun 30, 20254
  • AuditorCBIZ CPAs P.C., Boston, MA PCAOB ID 1994
  • On EDGAR sinceDec 29, 20211
  • Filings106 in all: 8-K (17), 10-Q (11), NT 10-Q (10), 3 (9), SC 13G (9), 425 (7), SCHEDULE 13G/A (5), CORRESP (4)1
    All 26 form types

    UPLOAD (4), 10-K (3), DEF 14A (3), NT 10-K (3), PRE 14A (3), S-1/A (3), SC 13G/A (3), DEFA14A (2), 10-K/A (1), 25-NSE (1), 4 (1), 424B4 (1), 8-A12B (1), CERT (1), DRS (1), EFFECT (1), PRER14A (1), S-1 (1)

  • Latest filingsAnnual report (10-K) Apr 9, 2026
    Quarterly report (10-Q) Aug 27, 2026
    Proxy statement (DEF 14A) Jul 29, 2026
    Latest 8-K (8-K) Sep 9, 2026

Securities registered for trading

ClassSymbolExchange
Units, each consisting of one Class A Ordinary Share, $0.0001 par value, and one-half of one redeemable warrantALCYUNasdaq
Class A Ordinary SharesALCYNasdaq
Redeemable warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50ALCYWNasdaq

From the cover page of the 10-K filed Apr 9, 2026 (Section 12(b) of the Exchange Act).4

Risk factors and legal proceedings

The risks Alchemy Investments Acquisition Corp 1 names in Item 1A of its 10-K filed Apr 9, 2026: 62 risks under these headings, as written.4

  • Risks Associated with Our Business
  • We are a blank check company with no operating history and, accordingly, you will not have any basis on which to evaluate our ability to achieve our business objective.
  • Our independent registered public accounting firm’s report contains an explanatory paragraph that expresses substantial doubt about our ability to continue as a “going concern.”
  • The requirement that we complete an initial business combination within a specific period of time may give potential target businesses leverage over us in negotiating our initial business combination and may limit the amount of time we have to conduct due diligence on potential business combination targets as we approach our dissolution deadline, which could undermine our ability to consummate our initial business combination on terms that would produce value for our shareholders.
  • We have entered into a definitive agreement for an initial business combination, but the Business Combination may not be consummated, in which case we may be required to liquidate.
  • You will not be entitled to protections normally afforded to investors of blank check companies.
  • Our sponsor paid an aggregate of $50,000 for the founder shares, or approximately $0.0116 per founder share. As a result of this low initial price, our sponsor, its affiliates and our management team stand to make a substantial profit even if an initial business combination subsequently declines in value or is unprofitable for our public shareholders.
  • We may issue additional Ordinary Shares, preference shares or debt securities to complete a business combination, which would reduce the equity interest of our shareholders and likely cause a change in control of our ownership.
  • We may be unable to obtain additional financing, if required, to complete a business combination or to fund the operations and growth of the target business, which could compel us to restructure or abandon a particular business combination.
  • If third parties bring claims against us, the proceeds held in trust could be reduced and the per-share liquidation price received by shareholders may be less than $10.15.
  • Our shareholders may be held liable for claims by third parties against us to the extent of distributions received by them.
  • Changes in the market for directors and officers liability insurance could make it more difficult and more expensive for us to negotiate and complete an initial business combination.
The other 51 risks
  • We depend on a variety of U.S. and multi-national financial institutions to provide us with banking services. The default or failure of one or more of the financial institutions that we rely on may adversely affect our business and financial condition.
  • Changes to laws or regulations or in how such laws or regulations are interpreted or applied, or a failure to comply with any laws, regulations, interpretations or applications, may adversely affect our business, including our ability to negotiate and complete our initial business combination.
  • Recent increases in inflation and interest rates in the United States and elsewhere could make it more difficult for us to consummate an initial business combination.
  • Resources could be wasted in researching acquisitions that are not completed, which could materially adversely affect subsequent attempts to locate and acquire or merge with another business. If we have not completed our initial business combination within the required time period, our public shareholders may receive only approximately $10.15 per share, or less than such amount in certain circumstances, on the liquidation of our trust account and our warrants will expire worthless.
  • Holders of warrants will not have redemption rights if we are unable to complete an initial business combination within the required time period.
  • We have no obligation to net cash settle the warrants.
  • If we do not maintain a current and effective prospectus relating to the Ordinary Shares issuable upon exercise of the redeemable warrants, holders will only be able to exercise such redeemable warrants on a “cashless basis” which would result in a fewer number of shares being issued to the holder had such holder exercised the redeemable warrants for cash.
  • An investor will only be able to exercise warrants if the issuance of Ordinary Shares upon such exercise has been registered or qualified or is deemed exempt under the securities laws of the state of residence of the holder of the warrants.
  • Our management’s ability to require holders of our redeemable warrants to exercise such redeemable warrants on a cashless basis will cause holders to receive fewer Ordinary Shares upon their exercise of the redeemable warrants than they would have received had they been able to exercise their redeemable warrants for cash.
  • The requirement that the target business or businesses that we acquire must collectively have a fair market value equal to at least 80% of the balance of the funds in the trust account (less any deferred underwriting commissions and taxes payable on the interest earned on the trust account) at the time of the execution of a definitive agreement for our initial business combination may limit the type and number of companies that we may complete such a business combination with.
  • Nasdaq may delist our securities if we do not consummate a business combination within the timeframe required by Nasdaq listing rules, which could materially adversely affect our liquidity and ability to complete a transaction.
  • Our ability to successfully effect a business combination and to be successful thereafter will be entirely dependent upon the efforts of our key personnel, some of whom may join us following a business combination. While we intend to closely scrutinize any individuals we engage after a business combination, we cannot assure you that our assessment of these individuals will prove to be correct.
  • Our officers and directors may not have significant experience or knowledge regarding industry of the target business we may seek to acquire.
  • Our key personnel may negotiate employment or consulting agreements with a target business in connection with a particular business combination. These agreements may provide for them to receive compensation following a business combination and as a result, may cause them to have conflicts of interest in determining whether a particular business combination is the most advantageous.
  • Our officers and directors will allocate their time to other businesses thereby potentially limiting the amount of time they devote to our affairs. This conflict of interest could have a negative impact on our ability to consummate our initial business combination.
  • Our officers and directors have pre-existing fiduciary and contractual obligations and accordingly, may have conflicts of interest in determining to which entity a particular business opportunity should be presented.
  • Our officers’ and directors’ personal and financial interests may influence their motivation in determining whether a particular target business is appropriate for a business combination.
  • Members of our management team and board of directors have significant experience as founders, board members, officers, executives or employees of other companies. Certain of those persons have been, may be, or may become, involved in litigation, investigations or other proceedings, including related to those companies or otherwise. The defense or prosecution of these matters could be time-consuming and could divert our management’s attention, and may have an adverse effect on us, which may impede our ability to consummate an initial business combination.
  • We may only be able to complete one business combination with the proceeds of our initial public offering, which will cause us to be solely dependent on a single business which may have a limited number of products or services.
  • We may be unable to consummate a business combination if a target business requires that we have cash in excess of the minimum amount we are required to have at closing and public shareholders may have to remain shareholders of our company and wait until our liquidation to receive a pro rata share of the trust account or attempt to sell their shares in the open market.
  • Our public shareholders may not be afforded an opportunity to vote on our proposed business combination, which means we may consummate our initial business combination even though a majority of our public shareholders do not support such a combination.
  • If we seek shareholder approval of our initial business combination, our sponsor has agreed to vote in favor of such initial business combination, regardless of how our public shareholders vote.
  • In connection with any meeting held to approve an initial business combination, we will offer each public shareholder the option to vote in favor of a proposed business combination and still seek redemption of his, her or its public shares, which may make it more likely that we will consummate a business combination.
  • In connection with any shareholder meeting called to approve a proposed initial business combination, we may require shareholders who wish to redeem their public shares to comply with specific requirements for redemption that may make it more difficult for them to exercise their redemption rights prior to the deadline for exercising their rights.
  • Investors may not have sufficient time to comply with the delivery requirements for redemption.
  • If we require public shareholders who wish to redeem their public shares to comply with the delivery requirements for redemption, such redeeming shareholders may be unable to sell their securities when they wish to in the event that the proposed business combination is not approved.
  • As a result of our limited resources and the significant competition for business combination opportunities, it may be more difficult for us to consummate an attractive business combination. This could increase the cost of our initial business combination and could even result in our inability to find a target or to consummate an initial business combination.
  • We may issue our shares to investors in connection with our initial business combination at a price that is less than the prevailing market price of our shares at that time.
  • The nominal purchase price paid by our sponsor for the founder shares may result in significant dilution to the implied value of your public shares upon the consummation of our initial business combination.
  • The value of the founder shares following completion of our initial business combination is likely to be substantially higher than the nominal price paid for them, even if the trading price of our ordinary shares at such time is substantially less than $10.00 per share.
  • Unlike some other similarly structured special purpose acquisition companies, our sponsor will receive additional Class A Ordinary Shares if we issue certain shares to consummate an initial business combination.
  • We may amend the terms of the warrants in a manner that may be adverse to holders of public warrants with the approval by the holders of at least a majority of the then outstanding public warrants, respectively. As a result, the exercise price of your warrants could be increased, the exercise period could be shortened and the number of Class A Ordinary Shares purchasable upon exercise of a warrant could be decreased, all without your approval.
  • Our warrant agreement designates the courts of the State of New York or the United States District Court for the Southern District of New York as the sole and exclusive forum for certain types of actions and proceedings that may be initiated by holders of our warrants, which could limit the ability of warrant holders to obtain a favorable judicial forum for disputes with our company.
  • We may redeem your unexpired warrants prior to their exercise at a time that is disadvantageous to you, thereby making your warrants worthless.
  • Our warrants may have an adverse effect on the market price of our Class A Ordinary Shares and make it more difficult to effectuate a business combination.
  • We may not be able to complete an initial business combination since such initial business combination may be subject to regulatory review and approval requirement, including foreign investment regulations and review by government entities such as the Committee on Foreign Investment in the United States (“CFIUS”), or may be ultimately prohibited.
  • We may not seek an opinion from an unaffiliated third party as to the fair market value of the target business we acquire.
  • We may acquire a target business that is affiliated with our officers, directors, sponsor or their affiliates.
  • A provision of our warrant agreement may make it more difficult for us to consummate an initial business combination.
  • Risks Related to Being Deemed an Investment Company
  • If we were deemed to be an investment company for purposes of the Investment Company Act of 1940, as amended (the “Investment Company Act”), we may be forced to abandon our efforts to complete the Proposed Business Combination and instead be required to liquidate the Company.
  • We may be a passive foreign investment company, or “PFIC,” which could result in adverse U.S. federal income tax consequences to U.S. investors.
  • We may reincorporate in another jurisdiction in connection with our initial business combination and such reincorporation may result in taxes imposed on shareholders.
  • Provisions in our amended and restated memorandum and articles of association and Cayman Islands law may inhibit a takeover of us, which could limit the price investors might be willing to pay in the future for our Class A Ordinary Shares and could entrench management.
  • As we are incorporated under the laws of the Cayman Islands, our shareholders may face difficulties in protecting their interests, and their ability to protect their rights through the U.S. federal courts may be limited.
  • We may effect a business combination with a company located outside of the United States and if we do, we would be subject to a variety of additional risks that may negatively impact our business operations and financial results.
  • If we effect a business combination with a company located outside of the United States, the laws applicable to such company will likely govern all of our material agreements and we may not be able to enforce our legal rights.
  • Because we must furnish our shareholders with financial statements of the target business prepared in accordance with principles generally accepted in the United States of America (“U.S. GAAP”) or international financial reporting standards (“IFRS”) as issued by the International Accounting Standards Board or reconciled to U.S. GAAP, we may not be able to complete an initial business combination with some prospective target businesses.
  • Compliance with the Sarbanes-Oxley Act will require substantial financial and management resources and may increase the time and costs of completing an acquisition.
  • We are an “emerging growth company” and we cannot be certain if the reduced disclosure requirements applicable to emerging growth companies will make our securities less attractive to investors.
  • If our management following a business combination is unfamiliar with United States securities laws, they may have to expend time and resources becoming familiar with such laws which could lead to various regulatory issues.
  • Our shareholders may be held liable for claims by third parties against us to the extent of distributions received by them upon redemption of their shares.

Legal proceedings

To the knowledge of management, there is no material litigation, arbitration or governmental proceeding currently pending against us, any of our officers or directors in their capacity as such or against any of our property.

The opening of Item 3, Legal Proceedings.4

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
  38. 38